Gilead Sciences (GILD) Long-Term Investments (2009 - 2026)

Gilead Sciences (GILD) has reported Long-Term Investments for 17 consecutive years, with $983.0 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments changed N/A year-over-year to $983.0 million; the trailing twelve-month figure through Mar 2026 stood at $983.0 million (changed N/A YoY), and the FY2025 full-year result was $3.0 billion, changed N/A from the prior year.
• Long-Term Investments retreated to $983.0 million in Q1 2026 per GILD's latest filing, from $3.0 billion in the prior quarter.
• Across five years, Long-Term Investments topped out at $3.0 billion in Q4 2025 and bottomed at $983.0 million in Q1 2026.
• Historically, Long-Term Investments has averaged $1.5 billion across 4 years, with a median of $1.3 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Long-Term Investments surged 146.46% in 2022, then fell 9.83% in 2023.
• Over 4 years, Long-Term Investments stood at $1.2 billion in 2022, then declined by 6.59% to $1.2 billion in 2023, then soared by 155.72% to $3.0 billion in 2025, then tumbled by 66.95% to $983.0 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $983.0 million, $3.0 billion, and $2.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.